Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Blood|January 19, 2010
PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humansDalya R Soond, Elisa Bjørgo, Kristine Moltu, et al.
Cell Death Discovery|December 1, 2023
Standardized assays to monitor drug sensitivity in hematologic cancersPilar Ayuda-Durán, Johanne U Hermansen, Mariaserena Giliberto, et al.
Nature Communications|November 23, 2021
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patientsSynne Jenum, Kristian Tonby, Corina S Rueegg, et al.
Cell Reports Methods|April 14, 2023
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening dataAlvaro Köhn-Luque, Even Moa Myklebust, Dagim Shiferaw Tadele, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 20, 2012
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cellsJürgen Pollheimer, Johanna Bodin, Olav Sundnes, et al.
Iscience|May 26, 2020
Optic Atrophy 1 Controls Human Neuronal Development by Preventing Aberrant Nuclear DNA MethylationSafak Caglayan, Adnan Hashim, Artur Cieslar-Pobuda, et al.
Science Translational Medicine|February 25, 2021
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitisXiaojun Jiang, Annika Bergquist, Britt-Sabina Löscher, et al.
European Journal of Immunology|October 31, 2009
A novel human CD4+ T-cell inducer subset with potent immunostimulatory propertiesLishomwa C Ndhlovu, Fabio E Leal, Ijeoma G Eccles-James, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2022
Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic LeukemiaYanping Yin, Paschalis Athanasiadis, Linda Karlsen, et al.
Acta Oncologica (Stockholm, Sweden)|February 10, 2026
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trialKathinka Schmidt Slørdahl, Katarina Puco, Ragnhild Sørum Falk, et al.
Pageof 17